Correlation Between RAPT Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both RAPT Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAPT Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAPT Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on RAPT Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAPT Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAPT Therapeutics and Ikena Oncology.
Diversification Opportunities for RAPT Therapeutics and Ikena Oncology
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between RAPT and Ikena is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and RAPT Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAPT Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of RAPT Therapeutics i.e., RAPT Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between RAPT Therapeutics and Ikena Oncology
Given the investment horizon of 90 days RAPT Therapeutics is expected to generate 6.23 times more return on investment than Ikena Oncology. However, RAPT Therapeutics is 6.23 times more volatile than Ikena Oncology. It trades about 0.01 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.07 per unit of risk. If you would invest 206.00 in RAPT Therapeutics on November 28, 2024 and sell it today you would lose (91.00) from holding RAPT Therapeutics or give up 44.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
RAPT Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| RAPT Therapeutics |
| Ikena Oncology |
RAPT Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RAPT Therapeutics and Ikena Oncology
The main advantage of trading using opposite RAPT Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAPT Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| RAPT Therapeutics vs. Connect Biopharma Holdings | RAPT Therapeutics vs. Tyra Biosciences | RAPT Therapeutics vs. Xilio Development | RAPT Therapeutics vs. Mineralys Therapeutics, Common |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |